Coherus Q2 net loss narrows to $12.9M; UDENYCA sales up 60% YoY; appoints new CFO

Coherus Oncology, Inc.

2024-Q2 EPS reported $0.73 revenue$142,042,000

Q2 2024 net revenue $65.0M (+11% YoY); net loss $12.9M ($0.11 loss per share) vs $42.9M loss in Q2 2023.
UDENYCA net sales $50.9M (+60% YoY); market share 29% (+4 pts QoQ). LOQTORZI net sales $3.8M in first launch quarter.
Divestitures of CIMERLI and YUSIMRY generated $177.7M gain in H1 2024; repaid $250M term loan, replaced with $38.7M facility.
Pipeline: CHS-114 expansion cohorts enrolling; CHS-1000 IND cleared; casdozokitug Phase 2 planned Q4 2024.
Bryan McMichael appointed CFO, effective Aug 1, 2024; base salary $476K, 50% target bonus, 75,000 stock option grant.

item 2.02 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Bryan McMichael

Chief Financial Officer

CHRS · Coherus Oncology, Inc.

Effective: 2024-08-01
Filed: August 8, 2024, 7:59 PM ET

On August 7, 2024, the Company’s board of directors appointed Bryan McMichael, age 46, the Company’s current Interim Chief Financial Officer, Executive Vice President, Accounting, Corporate Controller, to serve as the Company’s Chief Financial Officer effective August 1, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Bryan McMichael was appointed as Chief Financial Officer at Coherus Oncology, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On August 7, 2024, the Company’s board of directors appointed Bryan McMichael, age 46, the Company’s current Interim Chief Financial Officer, Executive Vice President, Accounting, Corporate Controller, to serve as the Company’s Chief Financial Officer effective August 1, 2024.

View on SEC.gov

Coherus Oncology, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-24-011618

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.